Serum level of pigment epithelium derived factor (PEDF) is an independent determinant of resting heart rate in Japanese subjects

International Journal of Cardiology

Volumn 136, Issue 2, 2009, Pages 245-247

  Nakamura, Kazuo ^a   Yamagishi, Sho ichi ^b   Adachi, Hisashi ^b   Matsui, Takanori ^b   Kurita, Yayoi ^a   Inoue, Hiroyoshi ^b  

^a Nakamura Clinic   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiovascular disease; PEDF; Resting heart rate

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLUCOSE; PIGMENT EPITHELIUM DERIVED FACTOR;

AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD CHEMISTRY; FEMALE; HEART ATRIUM FIBRILLATION; HEART RATE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OUTPATIENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTING HEART RATE; RISK FACTOR; SMOKING; SYMPATHETIC NERVE;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; EYE PROTEINS; FEMALE; HEART RATE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NERVE GROWTH FACTORS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SERPINS;

EID: 67650766630     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.04.055     Document Type: Article

References (13)

1. Fox K., Borer J.S., Camm A.J., et al. Resting heart rate in cardiovascular disease. J Am Coll Cardiol 50 (2007) 823-830
2. Dyer A.R., Persky V., Stamler J., et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 112 (1980) 736-749
3. Gillum R.F., Makuc D.M., and Feldman J.J. Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. Am Heart J 121 (1991) 172-177
4. Palatini P. Elevated heart rate as a predictor of increased cardiovascular morbidity. J Hypertens 17 Suppl3 (1999) S3-S10
5. Tombran-Tink J., and Barnstable C.J. PEDF: a multifaceted neurotrophic factor. Nat Rev Neurosci 4 (2003) 628-636
6. Yamagishi S., Nakamura K., Matsui T., et al. Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. J Biol Chem 281 (2006) 20213-20220
7. Nakamura K., Yamagishi S., Matsui T., et al. Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation. Am J Pathol 170 (2007) 2159-2170
8. Yamagishi S., Adachi H., Abe A., et al. Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. J Clin Endocrinol Metab 91 (2006) 2447-2450.
9. Nakamura K., Yamagishi S., Adachi H., et al. Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes. Mol Med 13 (2007) 185-189
10. Nakamura K., Yamagishi S., Yoshida T., et al. Hydrogen peroxide stimulates pigment epithelium-derived factor gene and protein expression in the human hepatocyte cell line OUMS-29. J Int Med Res 35 (2007) 427-432
11. Nakamura K., Yamagishi S., Adachi H., Kurita-Nakamura Y., Matsui T., and Inoue H. Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes. Diabetes Metab Res Rev (2008) (in press)
12. Yamamoto E., Lai Z.F., Yamashita T., et al. Enhancement of cardiac oxidative stress by tachycardia and its critical role in cardiac hypertrophy and fibrosis. J Hypertens 24 (2006) 2057-2069
13. Phillips C.L., and Cistulli P.A. Obstructive sleep apnea and hypertension: epidemiology, mechanisms and treatment effects. Minerva Med 97 (2006) 299-312